Elite Pharmaceuticals, Inc. (ELTP) Current Income Tax Expense (Benefit)

Elite Pharmaceuticals, Inc. Current Income Tax Expense (Benefit)

Elite Pharmaceuticals, Inc. (ELTP) reported Current Income Tax Expense (Benefit) of $1.40 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-29.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-06-29

• Elite Pharmaceuticals, Inc. current income tax expense (benefit) for the quarter ending 2025-03-31 was $2.46M.
• Elite Pharmaceuticals, Inc. current income tax expense (benefit) for the quarter ending 2024-12-31 was -$239.18K, a 129.87% decline year-over-year.
• Elite Pharmaceuticals, Inc. current income tax expense (benefit) for the quarter ending 2024-09-30 was -$1.52M, a 108.59% decline year-over-year.
• Elite Pharmaceuticals, Inc. current income tax expense (benefit) for the quarter ending 2024-06-30 was $231.98K, a 49.69% increase year-over-year.
• Elite Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2026 was $1.40M, a 198.93% increase from fiscal 2025.
• Elite Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2025 was $468.00K, a 36.44% increase from fiscal 2024.
• Elite Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2024 was $343.00K, a 19.10% decline from fiscal 2023.
• Elite Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2023 was $424.00K.